Certain Transactions (Details) $ in Thousands, € in Millions |
1 Months Ended | 3 Months Ended | 12 Months Ended | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
Nov. 01, 2021
USD ($)
|
Jun. 02, 2020
USD ($)
|
Aug. 31, 2022
USD ($)
|
Feb. 16, 2021 |
Dec. 31, 2019 |
Dec. 31, 2022
USD ($)
|
Dec. 31, 2022
EUR (€)
|
Dec. 31, 2021
USD ($)
|
Dec. 31, 2020
USD ($)
|
Dec. 31, 2022
EUR (€)
|
|
| Certain Transactions (Details) [Line Items] | ||||||||||
| Aggregate purchase price | $ 97,100 | |||||||||
| Exchange agreement description | In exchange for 100% of the outstanding shares of Origin the Company issued 1,488 thousand ordinary shares, paid cash upon closing and is obligated to pay additional payments (combination of cash and shares) subject to performance-based earnouts over 3 years. | In exchange for 100% of the outstanding shares of Origin the Company issued 1,488 thousand ordinary shares, paid cash upon closing and is obligated to pay additional payments (combination of cash and shares) subject to performance-based earnouts over 3 years. | ||||||||
| Description of contingent payments | The total contingent payments could reach to a maximum aggregate amount of up to $40.0 million. Approximately 50% of the payments shall be settled in cash, and 50% shall be settled through the issuance of ordinary shares. | The total contingent payments could reach to a maximum aggregate amount of up to $40.0 million. Approximately 50% of the payments shall be settled in cash, and 50% shall be settled through the issuance of ordinary shares. | ||||||||
| Additional payment amount | $ 6,000 | |||||||||
| Retention period | 3 years | 3 years | ||||||||
| Intangible asset | $ 71,000 | |||||||||
| Intangible asset useful-life | 7 years | 7 years | ||||||||
| Aggregate purchase price | $ 29,300 | $ 42,300 | € 43 | |||||||
| Additional earn-out payment | 15 years | |||||||||
| Fair value | 23,800 | |||||||||
| Gain | 14,400 | |||||||||
| Changes in fair value of equity investment | $ 11,800 | |||||||||
| Total contingent payments aggregate amount | 21,000 | |||||||||
| Developed technology | 45,000 | |||||||||
| Liability amount | 14,200 | |||||||||
| Exchange for outstanding shares, percentage | 100.00% | |||||||||
| Net gain | $ 39,100 | 39,136 | ||||||||
| Other current assets | $ 105,600 | |||||||||
| Investment rate | 46.50% | 46.50% | ||||||||
| Intangible asset | $ 57,800 | |||||||||
| Goodwill | 22,300 | |||||||||
| Net assets | 25,500 | |||||||||
| Equity investment | 100,200 | |||||||||
| Net of share loss | 5,400 | |||||||||
| Potential earnout payment | 36,400 | € 37 | ||||||||
| Convertible notes | $ 1,900 | |||||||||
| Restructuring plan, percentage | 10.00% | |||||||||
| Employee related charges | $ 6,400 | |||||||||
| Other related charges | $ 3,900 | |||||||||
| Minimum [Member] | ||||||||||
| Certain Transactions (Details) [Line Items] | ||||||||||
| Intangible assets | 5 years | 5 years | ||||||||
| Maximum [Member] | ||||||||||
| Certain Transactions (Details) [Line Items] | ||||||||||
| Intangible assets | 10 years | 10 years | ||||||||
| LPW Technology [Member] | ||||||||||
| Certain Transactions (Details) [Line Items] | ||||||||||
| Changes in fair value of equity investment | $ 600 | |||||||||
| Related to Developed Technology [Member] | ||||||||||
| Certain Transactions (Details) [Line Items] | ||||||||||
| Intangible asset useful-life | 10 years | 10 years | ||||||||
| Related to Developed Technology [Member] | Minimum [Member] | ||||||||||
| Certain Transactions (Details) [Line Items] | ||||||||||
| Intangible assets | 7 years | 7 years | ||||||||
| Related to Developed Technology [Member] | Maximum [Member] | ||||||||||
| Certain Transactions (Details) [Line Items] | ||||||||||
| Intangible assets | 10 years | 10 years | ||||||||
| Marketable Equity Investment [Member] | ||||||||||
| Certain Transactions (Details) [Line Items] | ||||||||||
| Other current assets | $ 14,800 | |||||||||
| Xaar 3D [Member] | ||||||||||
| Certain Transactions (Details) [Line Items] | ||||||||||
| Investment, description | the Company entered into an agreement with Xaar to purchase additional shares of Xaar 3D that will increase its stake from 15 percent to 45 percent, with Xaar retaining the remaining 55 percent. | |||||||||
| Additional interest amount | $ 15,700 | |||||||||
| Remaining acquire share, percentage | 55.00% | |||||||||
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Additional payment amount. No definition available.
|
| X | ||||||||||
- Definition Amount of Aggregate purchase price. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Description of Contingent payments. No definition available.
|
| X | ||||||||||
- Definition Exchange agreement description. No definition available.
|
| X | ||||||||||
- Definition Exchange for outstanding shares, percentage. No definition available.
|
| X | ||||||||||
- Definition Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Restructuring plan, percentage. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Total contingent payments aggregate amount. No definition available.
|
| X | ||||||||||
- Definition Amount of acquirer's equity interest issued and issuable as part of consideration transferred in asset acquisition. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of net assets (liabilities). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Percentage of voting equity interests acquired at the acquisition date in the business combination. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The amount of expense in the period for communications and data processing expense. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Including the current and noncurrent portions, carrying amount of debt identified as being convertible into another form of financial instrument (typically the entity's common stock) as of the balance sheet date, which originally required full repayment more than twelve months after issuance or greater than the normal operating cycle of the company. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of gain (loss) from remeasurement to fair value of retained investment in former subsidiary and group of assets constituting business or nonprofit activity deconsolidated and derecognized, excluding conveyance of oil and gas mineral rights and transfer of product or service in contract with customer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The difference between cost and fair value added or subtracted from paid-in capital, arising from contribution of shares to an ESOP or commitments-to-release ESOP shares. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition For each line item in the statement of financial position, the amounts of gains and losses from fair value changes included in earnings. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. No definition available.
|
| X | ||||||||||
- Definition Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount before tax of foreign currency transaction realized gain (loss) recognized in the income statement. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Fair value portion of asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Description of expense limitation agreement. Includes, but is not limited to, term of carryover expense and expense in excess of expense limitation. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Rate of interest on investment. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Value of the investment at close of period. For schedules of investments that are categorized, the value would be aggregated by category. For investment in and advances to affiliates, if operations of any controlled companies are different in character from those of the company, group such affiliates within divisions and by type of activities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of liability position for contract or contract feature in long-duration contract issued by insurance entity that both protects contract holder from other-than-nominal capital market risk and exposes insurance entity to other-than-nominal capital market risk. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount after accumulated amortization of finite-lived and indefinite-lived intangible assets classified as other. No definition available.
|
| X | ||||||||||
- Definition Amount of current assets that are pledged or subject to withdrawal restrictions, classified as other. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The cash outflow associated with the purchase of noncontrolling interest during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Describes the maximum potential amount of consideration, undiscounted, that could be transferred under the registration payment arrangement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|